Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation

被引:2
|
作者
Van Lam Nguyen [1 ,2 ,3 ]
Ahn, Sangjin [1 ]
Pham Quang Hoa [1 ,2 ,3 ]
Nguyen Phuoc Long [1 ,2 ,3 ]
Ahn, Sangzin [1 ,2 ,3 ]
Cho, Yong-Soon [1 ,2 ,3 ,4 ]
Shin, Jae-Gook [1 ,2 ,3 ,4 ]
机构
[1] Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Busan, South Korea
[2] Inje Univ, Dept Pharmacol, Coll Med, 75 Bokji Ro, Busan 47392, South Korea
[3] Inje Univ, Pharmacogen Res Ctr, Coll Med, 75 Bokji Ro, Busan 47392, South Korea
[4] Inje Univ, Dept Clin Pharmacol, Busan Paik Hosp, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
ANTITUBERCULOSIS DRUGS;
D O I
10.4258/hir.2022.28.2.176
中图分类号
R-058 [];
学科分类号
摘要
Tuberculosis is an important global public health problem. Ranked above HIV/AIDS, it is considered the leading cause of death by a single infectious agent. According to the Global Tuberculosis Report 2020, tuberculosis causes 1.3 million deaths per year [1]. Although the mortality and incidence rates of tuberculosis in Korea have steadily decreased in recent years [2], the management of tuberculosis remains challenging and requires more effective efforts. In clinical settings, inadequate treatment leading to therapeutic failure and drug resistance was reported as a major challenge in tuberculosis management efforts [3,4]. Therefore, precision tuberculosis treatment strategies should be deployed to reach the global tuberculosis control targets.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 50 条
  • [41] Oncology in 2012: from personalized medicine to precision medicine
    J. F. Morere
    Targeted Oncology, 2012, 7 : 211 - 212
  • [42] Oncology in 2012: from personalized medicine to precision medicine
    Morere, J. F.
    TARGETED ONCOLOGY, 2012, 7 (04) : 211 - 212
  • [43] Bringing Personalized Medicine to Precision Medicine in Gastroesophageal Cancer
    Chao, Joseph
    Mehta, Arnav
    Klempner, Samuel Jacob
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [44] Perspective for Precision Medicine for Tuberculosis
    Lange, Christoph
    Aarnoutse, Rob
    Chesov, Dumitru
    van Crevel, Reinout
    Gillespie, Stephen H.
    Grobbel, Hans-Peter
    Kalsdorf, Barbara
    Kontsevaya, Irina
    van Laarhoven, Arjan
    Nishiguchi, Tomoki
    Mandalakas, Anna
    Merker, Matthias
    Niemann, Stefan
    Koehler, Niklas
    Heyckendorf, Jan
    Reimann, Maja
    Ruhwald, Morten
    Sanchez-Carballo, Patricia
    Schwudke, Dominik
    Waldow, Franziska
    DiNardo, Andrew R.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [45] Advances and promises of personalized precision medicine for metabolic diseases: Precision metabolic medicine
    Froguel, P.
    Bonnefond, A.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (02): : 199 - 203
  • [46] Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine
    Dragoi, Cristina Manuela
    Nicolae, Alina Crenguta
    Dumitrescu, Ion-Bogdan
    PHARMACEUTICS, 2024, 16 (08)
  • [47] Felix Frueh, Head of personalized medicine research and development at Medco
    Frueh, Felix
    PERSONALIZED MEDICINE, 2009, 6 (04) : 377 - 380
  • [48] The role of cytopathology practice and research in the development of personalized medicine in Iberoamerica
    Saieg, Mauro
    Lozano, Maria D.
    Perez-Machado, Miguel
    DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (09) : 819 - 820
  • [49] Genomic Medicine, Precision Medicine, Personalized Medicine: What's in a Name?
    Roden, D. M.
    Tyndale, R. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 168 - 171
  • [50] The future of precision medicine: towards a more predictive personalized medicine
    Elemento, Olivier
    EMERGING TOPICS IN LIFE SCIENCES, 2020, 4 (02) : 175 - 177